Literature DB >> 11092000

[Limb lengthening in dwarfism].

J Correll1, P Held.   

Abstract

Limb lengthening in dwarfism has become a standardised procedure with a good prognosis. In most cases external fixation is used. Gain of leg length up to 15 cm and more is possible in the lower leg and the femur and 8.5 cm in the humerus. Limb lengthening is useful in many cases of dwarfism due to skeletal dysplasia. There are a number of risks and possible complications involved and the procedure also requires considerable time. We report the results of 48 patients with dwarfism operated on in the Orthopädische Kinderklinik Aschau (Orthopaedic Hospital for Children). It must not be recommended as a normal tool in handling the problems of dwarfism, but it makes sense in some cases of dwarfism. We describe and discuss the prerequisites for the operative treatment.

Entities:  

Mesh:

Year:  2000        PMID: 11092000     DOI: 10.1007/s001320050527

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  5 in total

1.  Bilateral double level tibial lengthening in dwarfism.

Authors:  Rolf D Burghardt; Koichi Yoshino; Naoya Kashiwagi; Shigeo Yoshino; Anil Bhave; Dror Paley; John E Herzenberg
Journal:  J Orthop       Date:  2015-06-03

2.  [Spectrum of indications for intramedullary or external fixators for axis correction and limb lengthening].

Authors:  F Schiedel; R Rödl
Journal:  Orthopade       Date:  2013-12       Impact factor: 1.087

3.  Cosmetic stature lengthening: systematic review of outcomes and complications.

Authors:  Yousef Marwan; Dan Cohen; Mohammed Alotaibi; Abdullah Addar; Mitchell Bernstein; Reggie Hamdy
Journal:  Bone Joint Res       Date:  2020-07-08       Impact factor: 5.853

4.  [Achondroplasia and hypochondroplasia in paediatric orthopaedics].

Authors:  J Correll
Journal:  Orthopade       Date:  2008-01       Impact factor: 1.087

Review 5.  [Spondyloepiphyseal and metaphyseal dysplasia].

Authors:  T Wirth
Journal:  Orthopade       Date:  2008-01       Impact factor: 1.087

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.